2019


  1. Schuster S, Rubil S, Endres M, Princen HMG, Boeckel JN, Winter K, Werner C, Laufs U (2019). Anti-PCSK9 antibodies inhibit pro-atherogenic mechanisms in APOE*3Leiden.CETP mice. Sci Rep, 9), 11079-.
     
  2. Boeckel JN, Perret MF, Glaser SF, Seeger T, Heumuller AW, Chen W, John D, Kokot KE, Katus HA, Haas J, Lackner MK, Kayvanpour E, Grabe N, Dieterich C, von Haehling S, Ebner N, Hunecke S, Leuschner F, Fichtlscherer S, Meder B, Zeiher AM, Dimmeler S, Keller T (2019). Identification and regulation of the long non-coding RNA Heat2 in heart failure. J Mol Cell Cardiol, 126, 13-22.
     
  3. Polito MV, Stoebe S, Galasso G, De Rosa R, Citro R, Piscione F, Laufs U, Hagendorff A (2019). Analysis of Regional Right Ventricular Function by Tissue Doppler Imaging in Patients with Aortic Stenosis. J Cardiovasc Echogr, 29, 111-118.
     
  4. Hagendorff A, Doenst T, Falk V (2019). Echocardiographic assessment of functional mitral regurgitation: opening Pandora's box? ESC Heart Fail, 6, 678-685.
     
  5. Spies C, Metze M, Stobe S, Hagendorff A (2019). [Echocardiographic emergency diagnostics]. Herz, 44, 267-286.
     
  6. Farese GE, Tayal B, Stobe S, Laufs U, Hagendorff A (2019). Regional Disparities of Left Atrial Appendage Wall Contraction in Patients With Sinus Rhythm and Atrial Fibrillation. J Am Soc Echocardiogr, 32, 755-762.
     
  7. Hagendorff A, Evangelista A, Fehske W, Schafers HJ (2019). Improvement in the Assessment of Aortic Valve and Aortic Aneurysm Repair by 3-Dimensional Echocardiography. JACC Cardiovasc Imaging, 12, 2225-2244.
     
  8. Stobe S, Metze M, Spies C, Hagendorff A (2019). [Transesophageal echocardiography in emergency and intensive care medicine : Indication and implementation]. Med Klin Intensivmed Notfmed, 114, 490-498.
     
  9. Lenk K, Hagendorff A, Laufs U, Dahnert I (2019). Retrieval of an embolised occluder with an alligator forceps during staged paravalvular leakage closure. Clin Res Cardiol, 108, 824-827.
     
  10. Spies C, Laufs U, Hagendorff A, Metze M (2019). Case report: panic attacks as symptom of aortic regurgitation and aneurysm. Clin Res Cardiol, 108, 448-451.
     
  11. Pfeiffer D, Tebbenjohanns J, Klein N, Metze M, Neef M (2019). [History of catheter ablation]. Herzschrittmacherther Elektrophysiol, 30, 325-329.
     
  12. Neef M, Berndt K, Spies C, Laufs U, Metze M (2019). [Cardiac arrhythmias in patients with chronic autoimmune diseases]. Herzschrittmacherther Elektrophysiol, 30, 240-244.
     
  13. Lavall D, Jacobs N, Mahfoud F, Kolkhof P, Bohm M, Laufs U (2019). The non-steroidal mineralocorticoid receptor antagonist finerenone prevents cardiac fibrotic remodeling. Biochem Pharmacol, 168, 173-183.
     
  14. Bae YJ, Kratzsch J, Zeidler R, Fikenzer S, Werner C, Herm J, Jungehulsing GJ, Endres M, Haeusler KG, Thiery J, Laufs U (2019). Unraveling the steroid hormone response in male marathon runners: Correlation of running time with aldosterone and progesterone. J Steroid Biochem Mol Biol, 195, 105473-.
     
  15. Fikenzer S, Fikenzer K, Bauer Y, Kuehl M, Hindricks G, Bollmann A, Bode K (2019). Pain During "Noncomplex" Electrophysiological Studies and Cardiac Rhythm Device Surgery. J Cardiovasc Nurs, 34, 517-527.
     
  16. Schulz M, Griese-Mammen N, Anker SD, Koehler F, Ihle P, Ruckes C, Schumacher PM, Trenk D, Bohm M, Laufs U (2019). Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial. Eur J Heart Fail, 21, 1012-1021.
     
  17. Rudolph U, Laufs U (2019). [Cardiologic Check-ups]. Dtsch Med Wochenschr, 144, 1192-1201.
     
  18. Uphaus T, Bittner S, Groschel S, Steffen F, Muthuraman M, Wasser K, Weber-Kruger M, Zipp F, Wachter R, Groschel K (2019). NfL (Neurofilament Light Chain) Levels as a Predictive Marker for Long-Term Outcome After Ischemic Stroke. Stroke, 50, 3077-3084.
     
  19. Haarmann H, Koch J, Bonsch N, Mende M, Werhahn SM, Luers C, Stahrenberg R, Edelmann F, Holzendorf V, von Haehling S, Pieske B, Andreas S, Luthje L, Wachter R (2019). Morbidity and mortality in patients with cardiovascular risk factors and obstructive sleep apnoea: results from the DIAST-CHF cohort. Respir Med, 154, 127-132.
     
  20. Wachter R, Senni M, Belohlavek J, Straburzynska-Migaj E, Witte KK, Kobalava Z, Fonseca C, Goncalvesova E, Cavusoglu Y, Fernandez A, Chaaban S, Bohmer E, Pouleur AC, Mueller C, Tribouilloy C, Lonn E, A L Buraiki J, Gniot J, Mozheiko M, Lelonek M, Noe A, Schwende H, Bao W, Butylin D, Pascual-Figal D (2019). Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study. Eur J Heart Fail, 21, 998-1007.
     
  21. Schulz M, Griese-Mammen N, Anker SD, Koehler F, Ihle P, Ruckes C, Schumacher PM, Trenk D, Bohm M, Laufs U (2019). Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial. Eur J Heart Fail, 21, 1012-1021.
     
  22. Wasser K, Weber-Kruger M, Jurries F, Liman J, Hamann GF, Kermer P, Uphaus T, Protsenko E, Seegers J, Mende M, Groschel K, Wachter R (2019). The cardiac diagnostic work-up in stroke patients-A subanalysis of the Find-AFRANDOMISED trial. PLoS One, 14, 0216530-.
     
  23. Stegmann T, Wachter R, Schabitz WR (2019). [Embolic stroke of undetermined source (ESUS) : How much monitoring is necessary?] Herz, 44, 289-295.
     
  24. Wachter R, Fonseca AF, Balas B, Kap E, Engelhard J, Schlienger R, Klebs S, Wirta SB, Kostev K (2019). Real-world treatment patterns of sacubitril/valsartan: a longitudinal cohort study in Germany. Eur J Heart Fail, 21, 588-597.
     
  25. Uphaus T, Weber-Kruger M, Grond M, Toenges G, Jahn-Eimermacher A, Jauss M, Kirchhof P, Wachter R, Groschel K (2019). Development and validation of a score to detect paroxysmal atrial fibrillation after stroke. Neurology, 92, e115-e124.
     
  26. Katzmann JL, Tunnemann-Tarr A, Laufs U (2019). [European dyslipidemia guidelines 2019 : What is new?] Herz, 44, 688-695.
     
  27. Katzmann JL, Laufs U (2019). New Insights in the Control of Low-Density Lipoprotein Cholesterol to Prevent Cardiovascular Disease. Curr Cardiol Rep, 21, 69-.
     
  28. Werner CM, Hecksteden A, Morsch A, Bohm M, Meyer T, Laufs U (2019). Response to: Jiménez-Pavon et al. and Patanè. Eur Heart J, 40, 3201-.
     
  29. Metze M, Davierwala PM, Andreas H, Klingel K, Laufs U, Kloter T (2019). Progression of left ventricular thrombus in Loeffler's endocarditis without eosinophilia-case report and review of the literature. Clin Res Cardiol, 108, 1163-1170.
     
  30. Laufs U, Banach M, Mancini GBJ, Gaudet D, Bloedon LT, Sterling LR, Kelly S, Stroes ESG (2019). Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance. J Am Heart Assoc, 8, e011662-.
     
  31. Werner CM, Hecksteden A, Morsch A, Zundler J, Wegmann M, Kratzsch J, Thiery J, Hohl M, Bittenbring JT, Neumann F, Bohm M, Meyer T, Laufs U (2019). Differential effects of endurance, interval, and resistance training on telomerase activity and telomere length in a randomized, controlled study. Eur Heart J, 40, 34-46.
     
  32. Laufs U, Dent R, Kostenuik PJ, Toth PP, Catapano AL, Chapman MJ (2019). Why is hypercholesterolaemia so prevalent? A view from evolutionary medicine. Eur Heart J, 40, 2825-2830.
     
  33. Katzmann JL, Laufs U (2019). Why doesn't high cholesterol hurt? Aging (Albany NY), 11, 10788-10790.
     
  34. Katzmann L, Ference BA, Laufs U (2019). Prinzip der mendelschen Randomisierung und Anwendung in der kardiovaskulären Medizin Der Kardiologe, 13, 146-152.
     
  35. Katzmann JL, Laufs U (2019). Lipoprotein(a) in der Prädiktion kardiovaskulärer Ereignisse Deutsche Medizinische Wochenschrift, 144, 299-302.
     
  36. Kosiuk J, Uhe T, Stegmann C, Ueberham L, Bertagnolli L, Dagres N, Dinov B, Mussigbrodt A, Richter S, Paetsch I, Jahnke C, Hilbert S, Sommer P, Hindricks G, Bollmann A (2019). Morphological determinators of platelet activation status in patients with atrial fibrillation. Int J Cardiol, 279, 90-95.
     
  37. Metze M, Ussat M, Stöbe S (2019). Notfallmedizinische Untersuchung Schritt für Schritt Notfallmedizin up2date , 14, 1-17.
     
  38. Metze M, Ussat M, Stöbe S (2019). Notfallmedizinische Untersuchung bei bewusstlosen Patienten Notf.med. up2date, 14, 127-132.
     
  39. Bluher M, Laufs U (2019). New concepts for body shape-related cardiovascular risk: role of fat distribution and adipose tissue function. Eur Heart J, 40, 2856-2858.
     
  40. Kavalerchyk V, Stobe S, Hagendorff A, Augustyniak J, Staudt A (2019). [Right Atrial Thrombus Formation as Complications in the Presence of Hemodialysis Catheter and Central Venous Catheter]. Dtsch Med Wochenschr, 144, 1349-1353.
     
  41. Kornej J, Zeynalova S, Buttner P, Burkhardt R, Bae YJ, Willenberg A, Baber R, Thaler A, Hindricks G, Loeffler M, Hagendorff A, Thiele H, Thiery J (2019). Differentiation of atrial fibrillation progression phenotypes using Troponin T. Int J Cardiol, 297, 61-65.
     
  42. Kornej J, Zeynalova S, Thiery J, Burkhardt R, Baber R, Engel C, Hagendorff A, Loeffler M, Husser D (2019). Association between echocardiographic parameters and biomarkers in probands with atrial fibrillation and different PR interval lengths: Insight from the epidemiologic LIFE Adult Study. PLoS One, 14, 0212627-0212627.
     
  43. Manganaro R, Marchetta S, Dulgheru R, Ilardi F, Sugimoto T, Robinet S, Cimino S, Go YY, Bernard A, Kacharava G, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Hagendorff A, Hristova K, Lopez-Fernandez T, de la Morena G, Popescu BA, Penicka M, Ozyigit T, Rodrigo Carbonero JD, van de Veire N, Von Bardeleben RS, Vinereanu D, Zamorano JL, Rosca M, Calin A, Moonen M, Magne J, Cosyns B, Galli E, Donal E, Carerj S, Zito C, Santoro C, Galderisi M, Badano LP, Lang RM, Oury C, Lancellotti P (2019). Echocardiographic reference ranges for normal non-invasive myocardial work indices: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging, 20, 582-590.
     
  44. Desch S, Freund A, Graf T, Fichtlscherer S, Haake H, Preusch M, Hammer F, Akin I, Christ M, Liebetrau C, Skurk C, Steiner S, Voigt I, Schmitz R, Mudra H, Ledwoch J, Menck N, Horstkotte J, Pels K, Lahmann AL, Otto S, Lenk K, Ohlow MA, Hassager C, Nordbeck P, Zeymer U, Jobs A, de Waha-Thiele S, Olbrich D, Konig I, Klinge K, Thiele H (2019). Immediate unselected coronary angiography versus delayed triage in survivors of out-of-hospital cardiac arrest without ST-segment elevation: Design and rationale of the TOMAHAWK trial. Am Heart J, 209, 20-28.
     
  45. Ondruschka B, Babian C, Neef M, Zwirner J, Schwarz M (2019). Entomological and Cardiologic Evidence of Time Since Death in Short Postmortem Intervals. J Forensic Sci, 64, 1563-1567.
     
  46. Vukadinovic D, Vukadinovic AN, Lavall D, Laufs U, Wagenpfeil S, Bohm M (2019). Rate of Cough During Treatment With Angiotensin-Converting Enzyme Inhibitors: A Meta-Analysis of Randomized Placebo-Controlled Trials. Clin Pharmacol Ther, 105, 652-660.
     
  47. Falz R, Fikenzer S, Holzer R, Laufs U, Fikenzer K, Busse M (2019). Acute cardiopulmonary responses to strength training, high-intensity interval training and moderate-intensity continuous training. Eur J Appl Physiol, 119, 1513-1523.
     
  48. Falz R, Fikenzer S, Hoppe S, Busse M (2019). Normal Values of Hemoglobin Mass and Blood Volume in Young, Active Women and Men. Int J Sports Med, 40, 236-244.
     
  49. Hommel J, Ohmichen S, Rudolph UM, Hauser T, Schulz H (2019). Effects of six-week sprint interval or endurance training on calculated power in maximal lactate steady state. Biol Sport, 36, 47-54.
     
  50. Schnabel RB, Haeusler KG, Healey JS, Freedman B, Boriani G, Brachmann J, Brandes A, Bustamante A, Casadei B, Crijns HJGM, Doehner W, Engstrom G, Fauchier L, Friberg L, Gladstone DJ, Glotzer TV, Goto S, Hankey GJ, Harbison JA, Hobbs FDR, Johnson LSB, Kamel H, Kirchhof P, Korompoki E, Krieger DW, Lip GYH, Lochen ML, Mairesse GH, Montaner J, Neubeck L, Ntaios G, Piccini JP, Potpara TS, Quinn TJ, Reiffel JA, Ribeiro ALP, Rienstra M, Rosenqvist M, Sakis T, Sinner MF, Svendsen JH, Van Gelder IC, Wacht (2019). Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration. Circulation, 140, 1834-1850.
     
  51. Fangauf SV, Meyer T, Albus C, Binder L, Deter HC, Ladwig KH, Michal M, Ronel J, Rothenberger A, Sollner W, Wachter R, Weber CS, Herrmann-Lingen C (2019). Longitudinal relationship between B-type natriuretic peptide and anxiety in coronary heart disease patients with depression. J Psychosom Res, 123, 109728-.
     
  52. Diekmann S, Horster L, Evers S, Hiligsmann M, Gelbrich G, Groschel K, Wachter R, Hamann GF, Kermer P, Liman J, Weber-Kruger M, Wasem J, Neumann A (2019). Economic evaluation of prolonged and enhanced ECG Holter monitoring in acute ischemic stroke patients. Curr Med Res Opin, 35, 1859-1866.
     
  53. Verma A, Wachter R, Kowey PR, Halperin JL, Gersh BJ, Elkind MSV, Kaplon RE, Ziegler PD, Sherfesee L, Reiffel JA (2019). Changes in Management Following Detection of Previously Unknown Atrial Fibrillation by an Insertable Cardiac Monitor (from the REVEAL AF Study). Am J Cardiol, 124, 864-870.
     
  54. Tsivgoulis G, Katsanos AH, Grory BM, Kohrmann M, Ricci BA, Tsioufis K, Cutting S, Krogias C, Schellinger PD, Campello AR, Cuadrado-Godia E, Gladstone DJ, Sanna T, Wachter R, Furie K, Alexandrov AV, Yaghi S (2019). Prolonged Cardiac Rhythm Monitoring and Secondary Stroke Prevention in Patients With Cryptogenic Cerebral Ischemia. Stroke, 50, 2175-2180.
     
  55. Bahls M, Friedrich N, Pietzner M, Wachter R, Budde K, Hasenfuss G, Nauck M, Pressler A, Felix SB, Edelmann F, Halle M, Dorr M (2019). Heterogeneous Metabolic Response to Exercise Training in Heart Failure with Preserved Ejection Fraction. J Clin Med, 8, 591.
     
  56. Schertz A, Herbeck Belnap B, Chavanon ML, Edelmann F, Wachter R, Herrmann-Lingen C (2019). Motivational interviewing can support physical activity in elderly patients with diastolic heart failure: results from a pilot study. ESC Heart Fail, 6, 658-666.
     
  57. Nolte K, Herrmann-Lingen C, Platschek L, Holzendorf V, Pilz S, Tomaschitz A, Dungen HD, Angermann CE, Hasenfuss G, Pieske B, Wachter R, Edelmann F (2019). Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction. ESC Heart Fail, 6, 262-270.
     
  58. Sadlonova M, Meyer T, Binder L, Wachter R, Edelmann F, Herrmann-Lingen C (2019). Higher plasma levels of CT-proAVP are linked to less anxiety in men but not women with cardiovascular risk factors: Results from the observational Diast-CHF study. Psychoneuroendocrinology, 101, 272-277.
     
  59. Authors/Task Force Members (2019). 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis, 290, 140-205.
     
  60. Bluher M, Laufs U (2019). New concepts for body shape-related cardiovascular risk: role of fat distribution and adipose tissue function. Eur Heart J, 40, 2856-2858.
     
  61. Dressel A, Schmidt B, Schmidt N, Laufs U, Fath F, Chapman MJ, Grammer TB, Marz W (2019). Cost effectiveness of lifelong therapy with PCSK9 inhibitors for lowering cardiovascular events in patients with stable coronary artery disease: Insights from the Ludwigshafen Risk and Cardiovascular Health cohort. Vascul Pharmacol, 120, 106566-.
     
  62. Boujon V, Uhlemann R, Wegner S, Wright MB, Laufs U, Endres M, Kronenberg G, Gertz K (2019). Dual PPAR?/? agonist aleglitazar confers stroke protection in a model of mild focal brain ischemia in mice. J Mol Med (Berl), 97, 1127-1138.
     
  63. Weingartner O, Lutjohann D, Meyer S, Fuhrmann A, Cremers B, Seiler-Mussler S, Schott HF, Kerksiek A, Friedrichs S, Ulbricht U, Zawada A, Laufs U, Schulze PC, Scheller B, Fliser D, Bohm M, Sijbrands E, Heine GH (2019). Low serum lathosterol levels associate with fatal cardiovascular disease and excess all-cause mortality: a prospective cohort study. Clin Res Cardiol, 108, 1381-1385.
     
  64. Hollstein T, Vogt A, Grenkowitz T, Stojakovic T, Marz W, Laufs U, Bolukbasi B, Steinhagen-Thiessen E, Scharnagl H, Kassner U (2019). Treatment with PCSK9 inhibitors reduces atherogenic VLDL remnants in a real-world study. Vascul Pharmacol, 116, 8-15.
     
  65. Grammer TB, Dressel A, Gergei I, Kleber ME, Laufs U, Scharnagl H, Nixdorff U, Klotsche J, Pieper L, Pittrow D, Silber S, Wittchen HU, Marz W (2019). Cardiovascular risk algorithms in primary care: Results from the DETECT study. Sci Rep, 9, 1101-.
     
  66. Ihle P, Krueger K, Schubert I, Griese-Mammen N, Parrau N, Laufs U, Schulz M (2019). Comparison of Different Strategies to Measure Medication Adherence via Claims Data in Patients With Chronic Heart Failure. Clin Pharmacol Ther, 106, 211-218.
     
  67. Ference BA, Kastelein JJP, Ray KK, Ginsberg HN, Chapman MJ, Packard CJ, Laufs U, Oliver-Williams C, Wood AM, Butterworth AS, Di Angelantonio E, Danesh J, Nicholls SJ, Bhatt DL, Sabatine MS, Catapano AL (2019). Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease. JAMA, 321, 364-373.
     
  68. Slawik J, Adrian L, Hohl M, Lothschutz S, Laufs U, Bohm M (2019). Irregular pacing of ventricular cardiomyocytes induces pro-fibrotic signalling involving paracrine effects of transforming growth factor beta and connective tissue growth factor. Eur J Heart Fail, 21, 482-491.
     
  69. Hohneck AL, Fries P, Stroder J, Schneider G, Wagenpfeil S, Schirmer SH, Bohm M, Laufs U, Custodis F (2019). Effects of heart rate reduction with ivabradine on vascular stiffness and endothelial function in chronic stable coronary artery disease. J Hypertens, 37, 1023-1031.
     
  70. Reiner Z, Laufs U, Cosentino F, Landmesser U (2019). The year in cardiology 2018: prevention. Eur Heart J, 40(4), 336-344.
     
  71. Silbernagel G, Steiner LK, Hollstein T, Fauler G, Scharnagl H, Stojakovic T, Schumann F, Bolukbasi B, Marz W, Steinhagen-Thiessen E, Laufs U, Kassner U (2019). The interrelations between PCSK9 metabolism and cholesterol synthesis and absorption. J Lipid Res, 60, 161-167.
     
  72. Kosiuk J, Uhe T, Stegmann C, Ueberham L, Bertagnolli L, Dagres N, Dinov B, Mussigbrodt A, Richter S, Paetsch I, Jahnke C, Hilbert S, Sommer P, Hindricks G, Bollmann A (2019). Morphological determinators of platelet activation status in patients with atrial fibrillation. Int J Cardiol, 279, 90-95.
     
  73. Pfrepper C, Deters S, Metze M, Siegemund R, Gockel I, Petros S (2019). Metamizole inhibits arachidonic acid-induced platelet aggregation after surgery and impairs the effect of aspirin in hospitalized patients. Eur J Clin Pharmacol, 75, 777-784.
     
  74. Pfrepper C, Poenisch W, Pierer M, Metze M, Kaiser T, Petros S (2019). Inhibitor eradication in refractory acquired hemophilia with lenalidomide. Ann Hematol, 98, 1533-1535.
     


  75. 2018


  76. Katzmann JL, Mahfoud F, Bohm M, Schulz M, Laufs U (2018). Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk. Patient Prefer Adherence, 13, 9-19.
     
  77. Schuster S, Cabrera D, Arrese M, Feldstein AE (2018). Triggering and resolution of inflammation in NASH. Nat Rev Gastroenterol Hepatol, 15(6), 349-364.
     
  78. Ramsden CE, Hennebelle M, Schuster S, Keyes GS, Johnson CD, Kirpich IA, Dahlen JE, Horowitz MS, Zamora D, Feldstein AE, McClain CJ, Muhlhausler BS, Makrides M, Gibson RA, Taha AY (2018). Effects of diets enriched in linoleic acid and its peroxidation products on brain fatty acids, oxylipins, and aldehydes in mice. Biochim Biophys Acta Mol Cell Biol Lipids, 1863(10), 1206-1213.
     
  79. Schuster S, Johnson CD, Hennebelle M, Holtmann T, Taha AY, Kirpich IA, Eguchi A, Ramsden CE, Papouchado BG, McClain CJ, Feldstein AE (2018). Oxidized linoleic acid metabolites induce liver mitochondrial dysfunction, apoptosis, and NLRP3 activation in mice. J Lipid Res, 59(9), 1597-1609.
     
  80. Heumuller AW, Boeckel JN (2018). Characterization and Validation of Circular RNA and Their Host Gene mRNA Expression Using PCR. Methods Mol Biol, 1724, 57-67.
     
  81. Herrmann-Lingen C, Meyer T, Bosbach A, Chavanon ML, Hassoun L, Edelmann F, Wachter R (2018). Cross-Sectional and Longitudinal Associations of Systolic Blood Pressure With Quality of Life and Depressive Mood in Older Adults With Cardiovascular Risk Factors: Results From the Observational DIAST-CHF Study. Psychosom Med, 80(5), 468-474.
     
  82. Wachter R, Groschel K (2018). [Acute treatment and secondary prophylaxis of ischemic stroke : An excellent example for personalized medicine]. Internist (Berl), 59(3), 241-251.
     
  83. Wachter R (2018). [Atrial fibrillation as a comorbidity of heart failure]. Internist (Berl), 59(5), 415-419.
     
  84. Wallbach M, Koziolek MJ, Wachter R (2018). [Baroreflex activation therapy : Indication and evidence in resistant hypertension and heart failure]. Internist (Berl), 59(10), 1011-1020.
     
  85. Pfrepper C, Peschka A, Weidhase L, Kaiser T, Petros S, Metze M (2018). Management of Dabigatran-associated bleeding in two elderly patients with acute renal failure. Ann Hematol, 97(12), 2519-2521.
     
  86. Hagendorff A, Stoebe S, Tayal B (2018). A systematic approach to 3D echocardiographic assessment of the aortic root. Glob Cardiol Sci Pract, 2018(2), 12-.
     
  87. Boeckel JN, Perret MF, Glaser SF, Seeger T, Heumuller AW, Chen W, John D, Kokot KE, Katus HA, Haas J, Lackner MK, Kayvanpour E, Grabe N, Dieterich C, von Haehling S, Ebner N, Hunecke S, Leuschner F, Fichtlscherer S, Meder B, Zeiher AM, Dimmeler S, Keller T (2018). Identification and regulation of the long non-coding RNA Heat2 in heart failure. J Mol Cell Cardiol, 126, 13-22.
     
  88. Eger N, Schoppe L, Schuster S, Laufs U, Boeckel JN (2018). Circular RNA Splicing. Adv Exp Med Biol, 1087, 41-52.
     
  89. Tschope C, Birner C, Bohm M, Bruder O, Frantz S, Luchner A, Maier L, Stork S, Kherad B, Laufs U (2018). Heart failure with preserved ejection fraction: current management and future strategies : Expert opinion on the behalf of the Nucleus of the "Heart Failure Working Group" of the German Society of Cardiology (DKG). Clin Res Cardiol, 107(1), 1-19.
     
  90. Schwarz V, Dusing P, Liman T, Werner C, Herm J, Bachelier K, Krull M, Brechtel L, Jungehulsing GJ, Haverkamp W, Bohm M, Endres M, Haeusler KG, Laufs U (2018). Marathon running increases circulating endothelial- and thrombocyte-derived microparticles. Eur J Prev Cardiol, 25(3), 317-324.
     
  91. Fox KM, Tai MH, Kostev K, Hatz M, Qian Y, Laufs U (2018). Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins. Clin Res Cardiol, 107(5), 380-388.
     
  92. Nordestgaard BG, Cosentino F, Landmesser U, Laufs U (2018). The year in cardiology 2017: prevention. Eur Heart J, 39(5), 345-353.
     
  93. Lavall D, Hagendorff A, Schirmer SH, Bohm M, Borger MA, Laufs U (2018). Mitral valve interventions in heart failure. ESC Heart Fail, 5(4), 552-561.
     
  94. Polito MV, Stoebe S, Leifels L, Stumpp P, Solty K, Galasso G, Piscione F, Laufs U, Klingel K, Hagendorff A (2018). Cardiac sarcoidosis: a challenging diagnosis. Clin Res Cardiol, 107, 980-986.
     
  95. Laufs U, Griese-Mammen N, Krueger K, Wachter A, Anker SD, Koehler F, Rettig-Ewen V, Botermann L, Strauch D, Trenk D, Bohm M, Schulz M (2018). PHARMacy-based interdisciplinary program for patients with Chronic Heart Failure (PHARM-CHF): rationale and design of a randomized controlled trial, and results of the pilot study. Eur J Heart Fail, 20, 1350-1359.
     
  96. Katzmann J, Schurfeld C, Marz W, Laufs U (2018). Case report-Rapid regression of xanthomas under lipoprotein apheresis in a boy with homozygous familial hypercholesterolemia. J Clin Lipidol, 12(4), 868-871.
     
  97. Laufs U, Weingartner O (2018). Pathological phenotypes of LDL particles. Eur Heart J, 39(27), 2574-2576.
     
  98. Lavall D, Mehrer M, Schirmer SH, Reil JC, Wagenpfeil S, Bohm M, Laufs U (2018). Long-Term Hemodynamic Improvement after Transcatheter Mitral Valve Repair. J Am Soc Echocardiogr, 31(9), 1013-1020.
     
  99. Fikenzer K, Fikenzer S, Laufs U, Werner C (2018). Effects of endurance training on serum lipids. Vascul Pharmacol, 101, 9-20.
     
  100. Kazakov A, Hall RA, Werner C, Meier T, Trouvain A, Rodionycheva S, Nickel A, Lammert F, Maack C, Bohm M, Laufs U (2018). Raf kinase inhibitor protein mediates myocardial fibrosis under conditions of enhanced myocardial oxidative stress. Basic Res Cardiol, 113(6), 42-.
     
  101. Fikenzer K, Fikenzer S, Laufs U, Werner C (2018). Effects of endurance training on serum lipids. Vascul Pharmacol, 101, 9-20.
     
  102. Nordestgaard BG, Cosentino F, Landmesser U, Laufs U (2018). The year in cardiology 2017: prevention. Eur Heart J, 39(5), 345-353.
     
  103. Pfeiffer D, Jurisch D, Monsuez JJ (2018). Cardiovascular Anniversaries in 2016. Eur Heart J, 39, 12-15.
     
  104. Wachter R, Viriato D, Klebs S, Grunow SS, Schindler M, Engelhard J, Proenca CC, Calado F, Schlienger R, Dworak M, Balas B, Bruce Wirta S (2018). Early insights into the characteristics and evolution of clinical parameters in a cohort of patients prescribed sacubitril/valsartan in Germany. Postgrad Med, 130(3), 308-316.
     
  105. Pfeiffer D, Monsuez JJ, Klein N (2018). Cardiovascular Anniversaries in 2016. European Heart Journal, 39(1), 12-15.
     
  106. Lavall D, Scheller B, Werner C, Buob A, Mahfoud F (2018). Mitral valve pressure gradient after percutaneous mitral valve repair: every beat counts. ESC Heart Fail, 5(1), 193-196.
     
  107. Pfeiffer D, Monsuez JJ, Neef M (2018). Cardiovascular Anniversaries in 2018. Eur Heart J, 39(36), 3349-3352.
     
  108. Heumuller AW, Boeckel JN (2018). Characterization and Validation of Circular RNA and Their Host Gene mRNA Expression Using PCR. Methods Mol Biol, 1724, 57-67.
     
  109. Stoebe S, Metze M, Jurisch D, Tayal B, Solty K, Laufs U, Pfeiffer D, Hagendorff A (2018). Analysis of chronic aortic regurgitation by 2D and 3D echocardiography and cardiac MRI. Echo Res Pract, 5, 51-62.
     
  110. Pfeiffer D, Monsuez JJ, Klein N (2018). Cardiovascular Anniversaries in 2017. Eur Heart J, 39, 1327-1329.
     
  111. Pfeiffer D (2018). Cardiovascular Anniversaries in 2016. Eur Heart J, 39, 12-15.
     
  112. Galderisi M, Donal E, Magne J, Lo Iudice F, Agricola E, Sade LE, Cameli M, Schwammenthal E, Cardim N, Cosyns B, Hagendorff A, Neskovic AN, Zamorano JL, Lancellotti P, Habib G, Edvardsen T, Popescu BA (2018). Rationale and design of the EACVI AFib Echo Europe Registry for assessing relationships of echocardiographic parameters with clinical thrombo-embolic and bleeding risk profile in non-valvular atrial fibrillation. Eur Heart J Cardiovasc Imaging, 19(3), 245-252.
     
  113. Krueger K, Griese-Mammen N, Schubert I, Kieble M, Botermann L, Laufs U, Kloft C, Schulz M (2018). In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review. Heart Fail Rev, 23(1), 63-71.
     
  114. Doehner W, Ural D, Haeusler KG, Celutkiene J, Bestetti R, Cavusoglu Y, Pena-Duque MA, Glavas D, Iacoviello M, Laufs U, Alvear RM, Mbakwem A, Piepoli MF, Rosen SD, Tsivgoulis G, Vitale C, Yilmaz MB, An (2018). Heart and brain interaction in patients with heart failure: overview and proposal for a taxonomy. A position paper from the Study Group on Heart and Brain Interaction of the Heart Failure Association. Eur J Heart Fail, 20(2), 199-215.
     
  115. Petersen J, Kazakov A, Bohm M, Schafers HJ, Laufs U, Abdul-Khaliq H (2018). Cardiopulmonary bypass reduces myocardial oxidative stress, inflammation and increases c-kit+CD45- cell population in newborns. J Transl Med, 16(1), 111-.
     
  116. Haeusler KG, Groschel K, Kohrmann M, Anker SD, Brachmann J, Bohm M, Diener HC, Doehner W, Endres M, Gerloff C, Huttner HB, Kaps M, Kirchhof P, Nabavi DG, Nolte CH, Pfeilschifter W, Pieske B, Poli S, S (2018). Expert opinion paper on atrial fibrillation detection after ischemic stroke. Clin Res Cardiol, 107(10), 871-880.
     
  117. Mach F, Ray KK, Wiklund O, Corsini A, Catapano AL, Bruckert E, De Backer G, Hegele RA, Hovingh GK, Jacobson TA, Krauss RM, Laufs U, Leiter LA, Marz W, Nordestgaard BG, Raal FJ, Roden M, Santos RD, Ste (2018). Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract. Eur Heart J, 39(27), 2526-2539.
     
  118. Selejan SR, Linz D, Tatu AM, Hohl M, Speer T, Ewen S, Mahfoud F, Kindermann I, Zamyatkin O, Kazakov A, Laufs U, Bohm M (2018). Sympathoadrenergic suppression improves heart function by upregulating the ratio of sRAGE/RAGE in hypertension with metabolic syndrome. J Mol Cell Cardiol, 122, 34-46.
     
  119. Fuhrmann A, Weingartner O, Meyer S, Cremers B, Seiler-Mussler S, Schott HF, Kerksiek A, Friedrichs S, Ulbricht U, Zawada AM, Laufs U, Scheller B, Fliser D, Schulze PC, Bohm M, Heine GH, Lutjohann D (2018). Plasma levels of the oxyphytosterol 7?-hydroxycampesterol are associated with cardiovascular events. Atherosclerosis, 279, 17-22.
     
  120. Haas J, Mester S, Lai A, Frese KS, Sedaghat-Hamedani F, Kayvanpour E, Rausch T, Nietsch R, Boeckel JN, Carstensen A, Volkers M, Dietrich C, Pils D, Amr A, Holzer DB, Martins Bordalo D, Oehler D, Weis (2018). Genomic structural variations lead to dysregulation of important coding and non-coding RNA species in dilated cardiomyopathy. EMBO Mol Med, 10(1), 107-120.
     
  121. Kavalerchyk V, Staudt A, Stoebe S, Hagendorff A, Wohlke M (2018). [Papillary Fibroelastoma of the Pulmonary and Tricuspid Valve in Asymptomatic Patients]. Dtsch Med Wochenschr, 143(20), 1484-1488.
     
  122. Steffen HJ, Kalverkamp S, Zayat R, Autschbach R, Spillner JW, Hagendorff A, Hatam N (2018). Is Systolic Right Ventricular Function Reduced after Thoracic Non-Cardiac Surgery? A Propensity Matched Echocardiographic Analysis. Ann Thorac Cardiovasc Surg, 24(5), 238-246.
     
  123. Sugimoto T, Robinet S, Dulgheru R, Bernard A, Ilardi F, Contu L, Addetia K, Caballero L, Kacharava G, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Hagendorff A, Hristova K, Lopez T, de la Morena (2018). Echocardiographic reference ranges for normal left atrial function parameters: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging, 19(6), 630-638.
     
  124. Galderisi M, Donal E, Magne J, Lo Iudice F, Agricola E, Sade LE, Cameli M, Schwammenthal E, Cardim N, Cosyns B, Hagendorff A, Neskovic AN, Zamorano JL, Lancellotti P, Habib G, Edvardsen T, Popescu BA (2018). Rationale and design of the EACVI AFib Echo Europe Registry for assessing relationships of echocardiographic parameters with clinical thrombo-embolic and bleeding risk profile in non-valvular atrial fibrillation. Eur Heart J Cardiovasc Imaging, 19(3), 245-252.
     
  125. Karliova I, Hagendorff A, Shalabi A, Schneider U, Schafers HJ (2018). Repair of a Quadricuspid Autograft. Ann Thorac Surg, 105(6), 251-253.
     
  126. Pelz JO, Harms K, Metze M, Michalski D (2018). Spontaneous cervical artery dissection is accompanied by a hypercoagulable state and simultaneous inflammatory condition. J Neurol, 265(2), 308-314.
     
  127. Wallbach M, Zurbig P, Dihazi H, Muller GA, Wachter R, Beige J, Koziolek MJ, Mischak H (2018). Kidney protective effects of baroreflex activation therapy in patients with resistant hypertension. J Clin Hypertens (Greenwich), 20(10), 1519-1526.
     
  128. Fangauf SV, Herbeck Belnap B, Meyer T, Albus C, Binder L, Deter HC, Ladwig KH, Michal M, Ronel J, Rothenberger A, Sollner W, Wachter R, Weber CS, Herrmann-Lingen C (2018). Associations of NT-proBNP and parameters of mental health in depressed coronary artery disease patients. Psychoneuroendocrinology, 96, 188-194.
     
  129. Pouleur AC, Anker S, Brito D, Brosteanu O, Hasenclever D, Casadei B, Edelmann F, Filippatos G, Gruson D, Ikonomidis I, Lhommel R, Mahmod M, Neubauer S, Persu A, Gerber BL, Piechnik S, Pieske B, Pieske (2018). Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH). ESC Heart Fail, 5(5), 830-841.
     
  130. Ravassa S, Trippel T, Bach D, Bachran D, Gonzalez A, Lopez B, Wachter R, Hasenfuss G, Delles C, Dominiczak AF, Pieske B, Diez J, Edelmann F (2018). Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial. Eur J Heart Fail, 20(9), 1290-1299.
     
  131. Siller-Matula JM, Pecen L, Patti G, Lucerna M, Kirchhof P, Lesiak M, Huber K, Verheugt FWA, Lang IM, Renda G, Schnabel RB, Wachter R, Kotecha D, Sellal JM, Rohla M, Ricci F, De Caterina R (2018). Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy. Int J Cardiol, 265, 141-147.
     
  132. Halbach M, Abraham WT, Butter C, Ducharme A, Klug D, Little WC, Reuter H, Schafer JE, Senni M, Swarup V, Wachter R, Weaver FA, Wilks SJ, Zile MR, Muller-Ehmsen J (2018). Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease. Int J Cardiol, 266, 187-192.
     
  133. Baldassarri F, Schwedhelm E, Atzler D, Boger RH, Cordts K, Haller B, Pressler A, Muller S, Suchy C, Wachter R, Dungen HD, Hasenfuss G, Pieske B, Halle M, Edelmann F, Duvinage A (2018). Relationship between exercise intervention and NO pathway in patients with heart failure with preserved ejection fraction. Biomarkers, 23(6), 540-550.
     
  134. Pascual-Figal D, Wachter R, Senni M, Belohlavek J, Noe A, Carr D, Butylin D (2018). Rationale and design of TRANSITION: a randomized trial of pre-discharge vs. post-discharge initiation of sacubitril/valsartan. ESC Heart Fail, 5(2), 327-336.
     
  135. Bobenko A, Bartels I, Munch M, Trippel T, Lindhorst R, Nolte K, Herrmann-Lingen C, Halle M, Duvinage A, Dungen HD, Gelbrich G, Tschope C, Hasenfuss G, Wachter R, Pieske B, Edelmann F (2018). Amount or intensity? Potential targets of exercise interventions in patients with heart failure with preserved ejection fraction. ESC Heart Fail, 5(1), 53-62.
     
  136. Senni M, McMurray JJV, Wachter R, McIntyre HF, Anand IS, Duino V, Sarkar A, Shi V, Charney A (2018). Impact of systolic blood pressure on the safety and tolerability of initiating and up-titrating sacubitril/valsartan in patients with heart failure and reduced ejection fraction: insights from the TITRATION study. Eur J Heart Fail, 20(3), 491-500.
     
  137. Gorter TM, van Veldhuisen DJ, Bauersachs J, Borlaug BA, Celutkiene J, Coats AJS, Crespo-Leiro MG, Guazzi M, Harjola VP, Heymans S, Hill L, Lainscak M, Lam CSP, Lund LH, Lyon AR, Mebazaa A, Mueller C, (2018). Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail, 20(1), 16-37.
     
  138. Grohmann T, Penke M, Petzold-Quinque S, Schuster S, Richter S, Kiess W, Garten A (2018). Inhibition of NAMPT sensitizes MOLT4 leukemia cells for etoposide treatment through the SIRT2-p53 pathway. Leuk Res, 69, 39-46.
     
  139. Sadlonova M, Meyer T, Binder L, Wachter R, Edelmann F, Herrmann-Lingen C (2018). Higher plasma levels of CT-proAVP are linked to less anxiety in men but not women with cardiovascular risk factors: Results from the observational Diast-CHF study. Psychoneuroendocrinology, 101, 272-277.
     
  140. Rosenkranz S, Lang IM, Blindt R, Bonderman D, Bruch L, Diller GP, Felgendreher R, Gerges C, Hohenforst-Schmidt W, Holt S, Jung C, Kindermann I, Kramer T, Kubler WM, Mitrovic V, Riedel A, Rieth A, Schm (2018). Pulmonary hypertension associated with left heart disease: Updated Recommendations of the Cologne Consensus Conference 2018. Int J Cardiol, 272, 53-62.
     
  141. Schmidt N, Dressel A, Grammer TB, Gouni-Berthold I, Julius U, Kassner U, Klose G, Konig C, Koenig W, Otte B, Parhofer KG, Reinhard W, Schatz U, Schunkert H, Steinhagen-Thiessen E, Vogt A, Laufs U, Mar (2018). Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry. Atherosclerosis, 277, 314-322.
     
  142. EAS Familial Hypercholesterolaemia Studies Collaboration (2018). Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). Atherosclerosis, 277, 234-255.
     
  143. Lutjohann D, Laufs U, Schulze PC, Weingartner O (2018). Call for an ezetimibe effectiveness test. Atherosclerosis, 278, 334-.
     
  144. Neef M, Bernhardt M (2018). Erst Allgemeinzustand-Verschlechterung, dann Vigilanzstörung, letztendlich AV Block III. Grades - was ist das? In: Weber CF, Meybohm P, Marung H, Schalk R, Stehr S, Gräsner J-T,Heinrichs W, Muellenbach RM , Erfahrungsschatz Notfallmedizin (S. 99-101), Stuttgart: Thieme.
     
  145. Metze M, Petros S (2018). Spezielles Blutungsmanagement bei Lebererkrankungen Intensivmedizin V6.2 In: Eckart, Forst, Briegel, Intensivmedizin (S. 1-33), Landsberg: ecomedMEDIZIN.
     


  146. 2017


  147. Pfeiffer D, Neef M, Jurisch D, Hagendorff A (2017). Komplikationen elektrophysiologischer Eingriffe im Alter. Herzschrittmacher und Elektrophysiologie, 28(1), 3-8.
     
  148. Hagendorff A, Stoebe S, Jurisch D, Neef M, Metze M, Pfeiffer D (2017). Neues und Bewährtes in der kardiologischen Diagnostik mithilfe der TEE. Herz, 43(3), 232-240.
     
  149. Wachter R, Freedman B (2017). The role of atrial fibrillation in patients with an embolic stroke of unknown source (ESUS). Thromb Haemost, 117(10), 1833-1835.
     
  150. Weber-Kruger M, Lutz C, Zapf A, Stahrenberg R, Seegers J, Witzenhausen J, Wasser K, Hasenfuss G, Groschel K, Wachter R (2017). Relevance of supraventricular runs detected after cerebral ischemia. Neurology, 89(15), 1545-1552.
     
  151. Callizo J, Feltgen N, Ammermann A, Ganser J, Bemme S, Bertelmann T, Pfeiffer S, Duvinage A, Groschel K, Hoerauf H, Wachter R (2017). Atrial fibrillation in retinal vascular occlusion disease and non-arteritic anterior ischemic optic neuropathy. PLoS One, 12(8), e0181766.
     
  152. Wachter R, Groschel K (2017). Atrial fibrillation in high-risk patients with ischaemic stroke - Authors reply. Lancet Neurol, 16(7), 498-498.
     
  153. Wachter R, Groschel K, Gelbrich G, Hamann GF, Kermer P, Liman J, Seegers J, Wasser K, Schulte A, Jurries F, Messerschmid A, Behnke N, Groschel S, Uphaus T, Grings A, Ibis T, Klimpe S, Wagner-Heck M, Arnold M, Protsenko E, Heuschmann PU, Conen D, Weber-Kruger M (2017). Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial. Lancet Neurol, 16(4), 282-290.
     
  154. Wachter R, Halbach M, Bakris GL, Bisognano JD, Haller H, Beige J, Kroon AA, Nadim MK, Lovett EG, Schafer JE, de Leeuw PW (2017). An exploratory propensity score matched comparison of second-generation and first-generation baroreflex activation therapy systems. J Am Soc Hypertens, 11(2), 81-91.
     
  155. Lavall D, Schuster P, Jacobs N, Kazakov A, Bohm M, Laufs U (2017). Rac1 GTPase regulates 11ß hydroxysteroid dehydrogenase type 2 and fibrotic remodeling. J Biol Chem, 292(18), 7542-7553.
     
  156. Adrian L, Lenski M, Todter K, Heeren J, Bohm M, Laufs U (2017). AMPK Prevents Palmitic Acid-Induced Apoptosis and Lipid Accumulation in Cardiomyocytes. Lipids, 52(9), 737-750.
     
  157. Adrian L, Werner C, Laufs U (2017). [ESC Guidelines 2016 - Heart Failure]. Dtsch Med Wochenschr, 142(15), 1123-1127.
     
  158. Perez-Ternero C, Werner CM, Nickel AG, Herrera MD, Motilva MJ, Bohm M, Alvarez de Sotomayor M, Laufs U (2017). Ferulic acid, a bioactive component of rice bran, improves oxidative stress and mitochondrial biogenesis and dynamics in mice and in human mononuclear cells. J Nutr Biochem, 48, 51-61.
     
  159. Laufs U, Jannowitz C, Pittrow D (2017). [Atorvastatin therapy under clinical practice conditions - which LDL-C levels are achieved in patients at very high cardiovascular risk?] Dtsch Med Wochenschr, 142(16), 1249-1252.
     
  160. Laufs U, Ference BA (2017). Vaccination to prevent atherosclerotic cardiovascular diseases. Eur Heart J, 38(32), 2508-2510.
     
  161. Laufs U (2017). Analysis of genes to predict the effects of proprotein convertase subtilisin/kexin type 9-inhibitors and statins. Cardiovasc Res, 113(6), e8-9.
     
  162. Laufs U, Filipiak KJ, Gouni-Berthold I, Catapano AL (2017). Practical aspects in the management of statin-associated muscle symptoms (SAMS). Atheroscler Suppl, 26, 45-55.
     
  163. Marz W, Kleber ME, Scharnagl H, Speer T, Zewinger S, Ritsch A, Parhofer KG, von Eckardstein A, Landmesser U, Laufs U (2017). HDL cholesterol: reappraisal of its clinical relevance. Clin Res Cardiol, 106(9), 663-675.
     
  164. Luchner A, von Haehling S, Holubarsch C, Keller T, Knebel F, Zugck C, Laufs U (2017). [Indications and Clinical Implications of the Use of the Cardiac Markers BNP and NT-proBNP]. Dtsch Med Wochenschr, 142(5), 346-355.
     
  165. Piepoli MF, Taddei S, Laufs U (2017). The year in cardiology 2016: prevention. Eur Heart J, 38(8), 542-549.
     
  166. Marz W, Kleber ME, Scharnagl H, Speer T, Zewinger S, Ritsch A, Parhofer KG, von Eckardstein A, Landmesser U, Laufs U (2017). [Clinical importance of HDL cholesterol]. Herz, 42(1), 58-66.
     
  167. Weingartner O, Bogeski I, Kummerow C, Schirmer SH, Husche C, Vanmierlo T, Wagenpfeil G, Hoth M, Bohm M, Lutjohann D, Laufs U (2017). Plant sterol ester diet supplementation increases serum plant sterols and markers of cholesterol synthesis, but has no effect on total cholesterol levels. J Steroid Biochem Mol Biol, 169, 219-225.
     
  168. Meyer-Saraei R, de Waha S, Eitel I, Desch S, Scheller B, Bohm M, Lauer B, Gawaz M, Geisler T, Gunkel O, Bruch L, Klein N, Pfeiffer D, Schuler G, Zeymer U, Thiele H (2017). Thrombus aspiration in non-ST-elevation myocardial infarction - 12-month clinical outcome of the randomised TATORT-NSTEMI trial. Eur Heart J Acute Cardiovasc Care, 6(1), 10-17.
     
  169. Zwirner J, Bayer R, Hadrich C, Bollmann A, Klein N, Dressler J, Ondruschka B (2017). Pulmonary artery perforation and coronary air embolism-two fatal outcomes in percutaneous left atrial appendage occlusion. Int J Legal Med, 131(1), 191-197.
     
  170. Trippel TD, Holzendorf V, Halle M, Gelbrich G, Nolte K, Duvinage A, Schwarz S, Rutscher T, Wiora J, Wachter R, Herrmann-Lingen C, Duengen HD, Hasenfuss G, Pieske B, Edelmann F (2017). Ghrelin and hormonal markers under exercise training in patients with heart failure with preserved ejection fraction: results from the Ex-DHF pilot study. ESC Heart Fail, 4(1), 56-65.
     
  171. Luers C, Trippel TD, Seelander S, Wachter R, Hasenfuss G, Lindhorst R, Bobenko A, Nolte K, Pieske B, Edelmann F (2017). Arterial stiffness and elevated left ventricular filling pressure in patients at risk for the development or a previous diagnosis of HF-A subgroup analysis from the DIAST-CHF study. J Am Soc Hypertens, 11(5), 303-313.
     
  172. Luers C, Edelmann F, Wachter R, Pieske B, Mende M, Angermann C, Ertl G, Dungen HD, Stork S (2017). Prognostic impact of diastolic dysfunction in systolic heart failure-A cross-project analysis from the German Competence Network Heart Failure. Clin Cardiol, 40(9), 667-673.
     
  173. Wild PS, Felix JF, Schillert A, Teumer A, Chen MH, Leening MJG, Volker U, Grossmann V, Brody JA, Irvin MR, Shah SJ, Pramana S, Lieb W, Schmidt R, Stanton AV, Malzahn D, Smith AV, Sundstrom J, Minelli (2017). Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function. J Clin Invest, 127(5), 1798-1812.
     
  174. Reiffel JA, Verma A, Kowey PR, Halperin JL, Gersh BJ, Wachter R, Pouliot E, Ziegler PD (2017). Incidence of Previously Undiagnosed Atrial Fibrillation Using Insertable Cardiac Monitors in a High-Risk Population: The REVEAL AF Study. JAMA Cardiol, 2(10), 1120-1127.
     
  175. Sugimoto T, Dulgheru R, Bernard A, Ilardi F, Contu L, Addetia K, Caballero L, Akhaladze N, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Hagendorff A, Hristova K, Lopez T, de la Morena G, Popescu (2017). Echocardiographic reference ranges for normal left ventricular 2D strain: results from the EACVI NORRE study. Eur Heart J Cardiovasc Imaging, 18(8), 833-840.
     
  176. Galderisi M, Cosyns B, Edvardsen T, Cardim N, Delgado V, Di Salvo G, Donal E, Sade LE, Ernande L, Garbi M, Grapsa J, Hagendorff A, Kamp O, Magne J, Santoro C, Stefanidis A, Lancellotti P, Popescu B, H (2017). Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging, 18(12), 1301-1310.
     
  177. Rasche FM, Stoebe S, Ebert T, Feige S, Hagendorff A, Rasche WG, Barinka F, Busch V, Sack U, Schneider JG, Schiekofer S (2017). Modern peptide biomarkers and echocardiography in cardiac healthy haemodialysis patients. BMC Nephrol, 18(1), 175.
     
  178. Lancellotti P, Galderisi M, Edvardsen T, Donal E, Goliasch G, Cardim N, Magne J, Laginha S, Hagendorff A, Haland TF, Aaberge L, Martinez C, Rapacciuolo A, Santoro C, Ilardi F, Postolache A, Dulgheru R (2017). Echo-Doppler estimation of left ventricular filling pressure: results of the multicentre EACVI Euro-Filling study. Eur Heart J Cardiovasc Imaging, 18(9), 961-968.
     
  179. Cadeddu C, Piras A, Dessi M, Madeddu C, Mantovani G, Scartozzi M, Hagendorff A, Colonna P, Mercuro G (2017). Timing of the negative effects of trastuzumab on cardiac mechanics after anthracycline chemotherapy. Int J Cardiovasc Imaging, 33(2), 197-207.
     
  180. Mueller UM, Walther C, Adam J, Fikenzer K, Erbs S, Mende M, Adams V, Linke A, Schuler G (2017). Endothelial Function in Children and Adolescents Is Mainly Influenced by Age, Sex and Physical Activity?- An Analysis of Reactive Hyperemic Peripheral Artery Tonometry. Circ J, 81(5), 717-725.
     
  181. Conti S, Reiffel JA, Gersh BJ, Kowey PR, Wachter R, Halperin JL, Kaplon RE, Pouliot E, Verma A (2017). Baseline Demographics, Safety, and Patient Acceptance of an Insertable Cardiac Monitor for Atrial Fibrillation Screening: The REVEAL-AF Study. J Atr Fibrillation, 9(5), 1551.
     
  182. Zelenak C, Radenovic S, Musial-Bright L, Tahirovic E, Sacirovic M, Lee CB, Jahandar-Lashki D, Inkrot S, Trippel TD, Busjahn A, Hashemi D, Wachter R, Pankuweit S, Stork S, Pieske B, Edelmann F, Dungen (2017). Heart failure awareness survey in Germany: general knowledge on heart failure remains poor. ESC Heart Fail, 4(3), 224-231.
     
  183. Maier IL, Schregel K, Karch A, Weber-Krueger M, Mikolajczyk RT, Stahrenberg R, Groschel K, Bahr M, Knauth M, Psychogios MN, Wachter R, Liman J (2017). Association between Embolic Stroke Patterns, ESUS Etiology, and New Diagnosis of Atrial Fibrillation: A Secondary Data Analysis of the Find-AF Trial. Stroke Res Treat, 2017, 1391843.
     
  184. Wandelt LK, Kowallick JT, Schuster A, Wachter R, Stumpfig T, Unterberg-Buchwald C, Steinmetz M, Ritter CO, Lotz J, Staab W (2017). Quantification of left atrial volume and phasic function using cardiovascular magnetic resonance imaging-comparison of biplane area-length method and Simpsons method. Int J Cardiovasc Imaging, 33(11), 1761-1769.
     
  185. Edelmann F, Bobenko A, Gelbrich G, Hasenfuss G, Herrmann-Lingen C, Duvinage A, Schwarz S, Mende M, Prettin C, Trippel T, Lindhorst R, Morris D, Pieske-Kraigher E, Nolte K, Dungen HD, Wachter R, Halle (2017). Exercise training in Diastolic Heart Failure (Ex-DHF): rationale and design of a multicentre, prospective, randomized, controlled, parallel group trial. Eur J Heart Fail, 19(8), 1067-1074.
     
  186. Uphaus T, Grings A, Groschel S, Muller A, Weber-Kruger M, Wachter R, Groschel K (2017). Automatic detection of paroxysmal atrial fibrillation in patients with ischaemic stroke: better than routine diagnostic workup? Eur J Neurol, 24(7), 990-994.
     
  187. Freedman B, Camm J, Calkins H, Healey JS, Rosenqvist M, Wang J, Albert CM, Anderson CS, Antoniou S, Benjamin EJ, Boriani G, Brachmann J, Brandes A, Chao TF, Conen D, Engdahl J, Fauchier L, Fitzmaurice (2017). Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration. Circulation, 135(9), 1851-1867.
     
  188. Hoeper MM, Lam CSP, Vachiery JL, Bauersachs J, Gerges C, Lang IM, Bonderman D, Olsson KM, Gibbs JSR, Dorfmuller P, Guazzi M, Galie N, Manes A, Handoko ML, Vonk-Noordegraaf A, Lankeit M, Konstantinides (2017). Pulmonary hypertension in heart failure with preserved ejection fraction: a plea for proper phenotyping and further research. Eur Heart J, 38(38), 2869-2873.
     
  189. Geisler T, Poli S, Meisner C, Schreieck J, Zuern CS, Nagele T, Brachmann J, Jung W, Gahn G, Schmid E, Baezner H, Keller T, Petzold GC, Schrickel JW, Liman J, Wachter R, Schon F, Schabet M, Lindner A, (2017). Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial): Rationale and study design. Int J Stroke, 12(9), 985-990.
     
  190. Jahandar Lashki D, Zelenak C, Tahirovic E, Trippel TD, Kolip P, Busjahn A, Rauchfuss M, Nolte K, Schwarz S, Wachter R, Gelbrich G, Halle M, Pieske B, Herrmann-Lingen C, Edelmann F, Dungen HD (2017). [Assessment of subjective physical well-being in heart failure : Validation of the FEW16 questionnaire]. Herz, 42(2), 200-208.
     
  191. Vukadinovic D, Lavall D, Vukadinovic AN, Pitt B, Wagenpfeil S, Bohm M (2017). True rate of mineralocorticoid receptor antagonists-related hyperkalemia in placebo-controlled trials: A meta-analysis. Am Heart J, 188, 99-108.
     
  192. Ference BA, Kastelein JJP, Ginsberg HN, Chapman MJ, Nicholls SJ, Ray KK, Packard CJ, Laufs U, Brook RD, Oliver-Williams C, Butterworth AS, Danesh J, Smith GD, Catapano AL, Sabatine MS (2017). Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk. JAMA, 318(10), 947-956.
     
  193. Bohm M, Laufs U, Mahfoud F, Schirmer SH, Kindermann I (2017). Primum non nocere: the dangers of deferring heart failure therapy. Eur J Heart Fail, 19(11), 1410-1411.
     
  194. Zewinger S, Kleber ME, Tragante V, McCubrey RO, Schmidt AF, Direk K, Laufs U, Werner C, Koenig W, Rothenbacher D, Mons U, Breitling LP, Brenner H, Jennings RT, Petrakis I, Triem S, Klug M, Filips A, B (2017). Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study. Lancet Diabetes Endocrinol, 5(7), 534-543.
     
  195. Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, Hegele RA, Krauss RM, Raal FJ, Schunkert H, Watts GF, Boren J, Fazio S, Horton JD, Masana L, Nicholls SJ, Nordestgaard BG, van de Slu (2017). Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J, 38(32), 2459-2472.
     
  196. Glerup S, Schulz R, Laufs U, Schluter KD (2017). Physiological and therapeutic regulation of PCSK9 activity in cardiovascular disease. Basic Res Cardiol, 112(3), 32.
     
  197. Zewinger S, Kleber ME, Rohrer L, Lehmann M, Triem S, Jennings RT, Petrakis I, Dressel A, Lepper PM, Scharnagl H, Ritsch A, Thorand B, Heier M, Meisinger C, de Las Heras Gala T, Koenig W, Wagenpfeil S, (2017). Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease. Eur Heart J, 38(20), 1597-1607.
     
  198. Scherer N, Dings C, Bohm M, Laufs U, Lehr T (2017). Alternative Treatment Regimens With the PCSK9 Inhibitors Alirocumab and Evolocumab: A Pharmacokinetic and Pharmacodynamic Modeling Approach. J Clin Pharmacol, 57(7), 846-854.
     
  199. Kohlhaas M, Nickel AG, Bergem S, Casadei B, Laufs U, Maack C (2017). Endogenous nitric oxide formation in cardiac myocytes does not control respiration during ß-adrenergic stimulation. J Physiol, 595(12), 3781-3798.
     
  200. Oesterle A, Laufs U, Liao JK (2017). Pleiotropic Effects of Statins on the Cardiovascular System. Circ Res, 120(1), 229-243.
     
  201. Schwarz V, Bachelier K, Schirmer SH, Werner C, Laufs U, Bohm M (2017). Red Wine Prevents the Acute Negative Vascular Effects of Smoking. Am J Med, 130(1), 95-100.
     
  202. Pusceddu I, Herrmann M, Kirsch SH, Werner C, Hubner U, Bodis M, Laufs U, Widmann T, Wagenpfeil S, Geisel J, Herrmann W (2017). One-carbon metabolites and telomere length in a prospective and randomized study of B- and/or D-vitamin supplementation. Eur J Nutr, 56(5), 1887-1898.
     
  203. Schott HF, Baumgartner S, Husche C, Luister A, Friedrichs S, Miller CM, McCarthy FO, Plat J, Laufs U, Weingartner O, Lutjohann D (2017). Oxidation of sitosterol and transport of its 7-oxygenated products from different tissues in humans and ApoE knockout mice. J Steroid Biochem Mol Biol, 169, 145-151.
     
  204. Hagendorff A (2017). System diseases and other conditions: Introduction./ Diseases with a main influence on heart valves./ Diseases with a main influence on Pericardium./ Coronary artery Imaging. In: Lancellotti P, Zamorano JL, Habib G, Badano L, The EACVI textbook of echocardiography (S. 472, 497-504, 597-60), Oxford: Oxford University Press.
     
  205. Hagendorff A, Stöbe S (2017). Basiswissen Echokardiographie. In: Hagendorff A, Stöbe S, Basiswissen Echokardiographie. (S. 1-392), München: Urban und Fischer Verlag/Elsevier GmbH.
     


  206. 2016


  207. Klein N, Pfeiffer D, Klein M (2016). Right apical, biventricular and right high septal ventricular pacing: A comparison of procedural burden and long term electrical performance. Archives of Medicine, 8, 1-11.
     
  208. Salameh A, Dhein S, Dahnert I, Klein N (2016). Neuroprotective Strategies during Cardiac Surgery with Cardiopulmonary Bypass. Int J Mol Sci, 17(11), 1945.
     
  209. Pfeiffer D, Jurisch D, Neef M, Hagendorff A (2016). [Alcohol and arrhythmias]. Herz, 41(6), 498-502.
     
  210. Klein N, Pfeiffer D, Goldberg S, Klein M (2016). Mitral Annuloplasty Device Implantation for Non-Surgical Treatment of Mitral Regurgitation: Clinical Experience After the Approval Studies. J Invasive Cardiol, 28(3), 115-120.
     
  211. Hagendorff A, Stöbe S (2016). Kontrastechokardiographie in der klinischen Praxis. Forum Sanitas, 4, 2-4.
     
  212. Waltenberger J, Brachmann J, van der Heyden J, Richardt G, Frobert O, Seige M, Erglis A, Dewilde W, Winkens M, Hegeler-Molkewehrum C, Klein N, Hoffmann S (2016). Real-world experience with a novel biodegradable polymer sirolimus-eluting stent: twelve-month results of the BIOFLOW-III registry. EuroIntervention, 11(10), 1106-1110.
     
  213. Asbach S, Lennerz C, Semmler V, Grebmer C, Solzbach U, Kloppe A, Klein N, Szendey I, Andrikopoulos G, Tzeis S, Bode C, Kolb C (2016). Impact of the Right Ventricular Lead Position on Clinical End Points in CRT Recipients--A Subanalysis of the Multicenter Randomized SPICE Trial. Pacing Clin Electrophysiol, 39(3), 261-267.
     
  214. Khamis H, Shimoni S, Hagendorff A, Smirin N, Friedman Z, Adam D (2016). Optimization-Based Speckle Tracking Algorithm for Left Ventricle Strain Estimation: A Feasibility Study. IEEE Trans Ultrason Ferroelectr Freq Control, 63(8), 1093-1106.
     
  215. Hobohm C, Hagendorff A, Schulz S, Fritzsch D, Budig S, Stobe S, Michalski D (2016). Clinical Presentation and Multi-Parametric Screening Surrogates of Ischemic Stroke Patients Suffering from Infective Endocarditis. Cerebrovasc Dis, 41(1-2), 60-67.
     


  216. 2015


  217. Hagendorff, A, Stoebe S, Jurisch D, Tarr A, Pfeiffer D (2015). Echokardiographische Parameter bei der diastolischen Herzinsuffizienz. Kardiologie up2date, 11(3), 133-136.
     
  218. Hagendorff A, Stoebe S, Tarr A, Pfeiffer D (2015). Standardized Transthoracic Echocardiography in Patients with Primary and Secondary Mitral Valve Regurgitation. Ultraschall Med, 36(1), 10-34.
     
  219. Pfeiffer D, Hagendorff A, Kuhne C, Reinhardt S, Klein N (2015). [Implantable cardioverter-defibrillator at the end of life]. Herzschrittmacherther Elektrophysiol, 26(2), 134-140.
     
  220. Reske AP, Reske AW, Metze M (2015). Complications of immunosuppressive agents therapy in transplant patients. Minerva Anaesthesiologica , 81(11), 1244-1261.
     
  221. Reinecke H, Braun M, Frankenstein L, Görge G, Kerlin A, Knoblich A, Kodolitsch Y von, Lengenfelder B, Levenson B, Pfeiffer D, Reichle B, (2015). Kriterien für die Notwendigkeit und Dauer von Krankenhausbehandlung bei Koronarographien und -interventionen. Der Kardiologe, 9(4), 295-302.
     
  222. Hammer N, Glatzner J, Feja C, Kuhne C, Meixensberger J, Planitzer U, Schleifenbaum S, Tillmann BN, Winkler D (2015). Human vagus nerve branching in the cervical region. PLoS One, 10(2), e0118006.
     
  223. Hammer N, Kuhne C, Meixensberger J, Hansel B, Winkler D (2015). Takotsubo cardiomyopathy - An unexpected complication in spine surgery. Int J Surg Case Rep, 6C, 172-174.
     
  224. Andrikopoulos G, Tzeis S, Asbach S, Semmler V, Lennerz C, Solzbach U, Grebmer C, Kloppe A, Klein N, Pastromas S, Biermann J, Kolb C (2015). A stepwise electrocardiographic algorithm for differentiation of mid-septal vs. apical right ventricular lead positioning: the SPICE ECG substudy. Europace, 17(6), 915-920.
     
  225. Loeffler M, Engel C, Ahnert P, Alfermann D, Arelin K, Baber R, Beutner F, Binder H, Brahler E, Burkhardt R, Ceglarek U, Enzenbach C, Fuchs M, Glaesmer H, Girlich F, Hagendorff A, Hantzsch M, Hegerl U, (2015). The LIFE-Adult-Study: objectives and design of a population-based cohort study with 10,000 deeply phenotyped adults in Germany. BMC Public Health, 15, 691.
     
  226. Zimmer J, Hawlitschek C, Rabald S, Hagendorff A, Zimmer HG, Rassler B (2015). Effects of late-onset and long-term captopril and nifedipine treatment in aged spontaneously hypertensive rats: Echocardiographic studies. Hypertens Res, 38(11), 716-722.
     
  227. Caballero L, Kou S, Dulgheru R, Gonjilashvili N, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Gomez de Diego JJ, Oliva MJ, Hagendorff A, Hristova K, Lopez T, Magne J, Martinez C, de la Morena G, (2015). Echocardiographic reference ranges for normal cardiac Doppler data: results from the NORRE Study. Eur Heart J Cardiovasc Imaging, 16(9), 1031-1041.
     
  228. Cardim N, Galderisi M, Edvardsen T, Plein S, Popescu BA, D Andrea A, Bruder O, Cosyns B, Davin L, Donal E, Freitas A, Habib G, Kitsiou A, Petersen SE, Schroeder S, Lancellotti P, Camici P et al (2015). Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association. Eur Heart J Cardiovasc Imaging, 16(3), 280.
     
  229. Hobohm C, Hagendorff A, Schulz S, Fritzsch D, Budig S, Stoebe S, Michalski D (2015). Clinical Presentation and Multi-Parametric Screening Surrogates of Ischemic Stroke Patients Suffering from Infective Endocarditis Cerebrovasc Dis, 41(1-2), 60-67.
     
  230. Hagendorff A (2015). Conventional echocardiography - Basic principles. In: Zamorano JL, Bax J, Knuuti J, Sechtem U, Lancelotti P, Badano L, The ESC textbook of cardiovascular imaging. (S. 3-32), Oxford: Oxford university press.
     
  231. Hagendorff A, Stoebe St (2015). Basics in transthoracic echocardiography and Standard documentation. In: Dietrich CF, EFSUMB Course book. (S. 2-21), London: EFSUMB.
     


  232. 2014


  233. Hagendorff A, Tiemann K, Simonis G, Campo dell´Orto M, von Bardeleben S (2014). Empfehlungen zur Notfallechokardiographie. Kardiologe, 8(1), 45-64.
     
  234. Stoebe S, Tarr A, Pfeiffer D, Hagendorff A (2014). The impact of width of the tracking area on the speckle tracking parameters - methodological aspects of deformation imaging. Echocardiography , 31(5), 586-596.
     
  235. Pfeiffer D, Jurisch D, Kluge JG, Hagendorff A, Klein N (2014). Medikamentöse Therapie des Vorhofflimmerns in speziellen Situationen Herzschrittmacher Elektrophysiol, 25(1), 26-32.
     
  236. Hagendorff A (2014). Coronary calcium score - does it matter in asymptomatic patients? - Contra view Eur Heart J, 35(20), 1296-1297.
     
  237. Stoebe S, Pfeiffer D, Hagendorff A (2014). Feasibility of 3D4D echocardiography for the detection of color-coded flow in the left anterior descendng artery echo research and practice, 1(1), 23-30.
     
  238. Trache T, Stoebe S, Tarr A, Pfeiffer D, Hagendorff A (2014). The agreement between 3D, standard 2D and triplane 2D speckle tracking: Effects of image quality and 3D volume rate Echo research and practice, 1(2), 71-83.
     
  239. Kou S, Caballero L, Dulgheru R, Voilliot D, De Sousa C, Kacharava G, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Gomez De Diego JJ, Hagendorff A, Henri C, Hristova K, Lopez T, Magne J, De La Mor (2014). Echocardiographic reference ranges for normal cardiac chamber size: results from the NORRE study. Eur Heart J Cardiovasc Imaging, 15(6), 680-690.
     
  240. Neskovic A, Edvardsen T, Galderisi M, Garbi M, Gullace G, Jurcut R, Dalen H, Hagendorff A, Lancelotti P (2014). Focus cardiac ultrasound: The European Association of cardiovascular ultrasound viewpoint. Eur Heart J Cardiovasc Imag, 15(9), 956-960.
     
  241. Doenst T, Amorim PA, Hagendorff A, Faerber G, Graff J, Rastan A, Deutsch O, Eichinger W (2014). Novel thoughts on patient-prosthesis mismatch in aortic valve replacement: the rationale for the PAR I trial. Thorac Cardiovasc Surg, 62(6), 463-468.
     
  242. Thiele H, de Waha S, Zeymer U, Desch S, Scheller B, Lauer B, Geisler T, Gawaz M, Gunkel O, Bruch L, Klein N, Pfeiffer D, Schuler G, Eitel I (2014). Effect of aspiration thrombectomy on microvascular obstruction in NSTEMI patients: the TATORT-NSTEMI trial JACC, 64(11), 1117-1124.
     
  243. Wiltberger G, Schmelzle M, Schubert S, Lubbert C, Brandmaier P, Berg T, Pfeiffer D, Rodloff A, Mohr FW, Jonas S (2014). Invasive cardiac aspergillosis after orthotopic liver transplantation. Z Gastroenterol, 52(8), 813-817.
     
  244. Tzeis S, Andrikopoulos G, Asbach S, Semmler V, Lennerz C, Solzbach U, Vrazic H, Kloppe A, Klein N, Pastromas S, Biermann J, Kolb C (2014). Electrocardiographic identification of prior myocardial infarction during right ventricular pacing - Effect of septal versus apical pacing. Int J Cardiol, 177(3), 977-981.
     
  245. Kolb C, Solzbach U, Biermann J, Semmler V, Kloppe A, Klein N, Lennerz C, Szendey I, Andrikopoulos G, Tzeis S, Asbach S (2014). Safety of mid-septal electrode placement in implantable cardioverter defibrillator recipients--results of the SPICE (Septal Positioning of ventricular ICD Electrodes) study. Int J Cardiol, 174(3), 713-720.
     
  246. Hammer N, Kuhne C, Meixensberger J, Hansel B, Winkler D (2014). Takotsubo cardiomyopathy - An unexpected complication in spine surgery. Int J Surg Case Rep, 6C, 172-174.
     


  247. 2013


  248. Jurisch D, Kluge JG, Pfeiffer D (2013). Akutes Rechtsherzversagen nach intravenöser Injektion von Heroin und Flunitrazepam. Dtsch Med Wochenschr, 138(22), 1159-1162.
     
  249. Hagendorff A, Stobe S, Tarr A, Pfeiffer D (2013). [Special echocardiographic diagnosis and specific problem constellations in patients with degenerative stenosis of the aortic valve]. Ultraschall Med, 34(3), 214-232.
     
  250. Hagendorff A, Freytag S, Muller A, Klebs S (2013). Pill burden in hypertensive patients treated with single-pill combination therapy-an observational study. Adv Ther, 30(4), 406-419.
     
  251. Hagendorff A (2013). Herz-Ultraschall auf dem Vormarsch? Management und Krankenhaus, 11, 12.
     
  252. Pfeiffer D, von Kodolitsch Y, Schächinger V, Haude M, Willems S, Nowak B (2013). Stellungnahme der Deutschen Gesellschaft für Kardiologie - Herz- und Kreislaufforschung zur Durchführung elektiver kardiovaskulärer Interventionen am Aufnahmetag. Kardiologe, 7(6), 423-428.
     
  253. Klein N, Klein M, Pfeiffer D (2013). Schrittmacher, kardiale Resynchronisation, implantierbarer Kardioverter/Defibrillator, Eventmonitoring. Dtsch Med Wochenschr, 138(49), 2526-2529.
     
  254. Tarr A, Stobe S, Trache T, Kluge JG, Varga A, Pfeiffer D, Hagendorff A (2013). The impact of foreshortening on regional strain--a comparison of regional strain evaluation between speckle tracking and tissue velocity imaging. Ultraschall Med, 34(5), 446-453.
     
  255. Hagendorff A, Stöbe S (2013). Notfall-Echokardiographie. Kardiologie up2date, 9(2), 119-129.
     
  256. Hagendorff A, Stöbe S (2013). Hypertrophe Kardiomyopathie. Wie sinnvoll ist ein systematisches Screening mittels Ultraschall. medicalsports network, 5, 2-6.
     
  257. de Waha S, Eitel I, Desch S, Scheller B, Böhm M, Lauer B, Gawaz M, Geisler T, Gunkel O, Bruch L, Klein N, Pfeiffer D, Schuler G, Zeymer U, Thiele H (2013). Thrombus aspiration in thrombus containing culprit lesion in non ST elevation myocardial infarction: study protocol for a randomized controlled trial Trials , 14, 110.
     
  258. Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA, Badano L, Zamorano JL (2013). Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging, 14(7), 611-644.
     
  259. Lancellotti P, Badano LP, Lang RM, Akhaladze N, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Gomez de Diego JJ, Derumeaux G, Dulgheru R, Edvardsen T, Galderisi M, Goncalves A, Habib G, Hagendorff (2013). Normal Reference Ranges for Echocardiography: rationale, study design, and methodology (NORRE Study). Eur Heart J Cardiovasc Imaging, 14(4), 303-308.
     
  260. Neskovic AN, Hagendorff A, Lancellotti P, Guarracino F, Varga A, Cosyns B, Flachskampf FA, Popescu BA, Gargani L, Zamorano JL, Badano LP (2013). Emergency echocardiography: the European Association of Cardiovascular Imaging recommendations. Eur Heart J Cardiovasc Imaging, 14(1), 1-11.
     
  261. Pfeiffer D, Klein N, Hagendorff A (2013). Akute Linksherzinsuffizienz. In: Kluge S, Markewitz A, Muhl E, Outensen C, Quintel M, Sybrecht GW, DIVI Jahrbuch 2013/2014: Fortbildung und Wissenschaft in der interdiszipülinären Intensivmedizin und Notfallmedizin. (S. 115-118), Berlin: Medizinisch Wissenschaftliche Verlagsgesellschaft.
     
  262. Hagendorff A (2013). Thoraxschmerz. In: Blank W, Mathis G, Osterwalder J, Kursbuch Notfallsonographie. (S. 127-135), Stuttgart, New York: Georg Thieme Verlag.
     
  263. Hagendorff A (2013). Anatomie, Normalbefunde, Standardschnitte - Teil 2. In: Blank W, Mathis G, Osterwalder J, Kursbuch Notfallsonographie. (S. 206-212), Stuttgart, New York: Georg Thieme Verlag.
     


  264. 2012


  265. Pfeiffer D, Rennie N, Papst CC, Zhang J (2012). Efficacy and Tolerability of Aliskiren/Amlodipine Single-Pill Combinations in Patients who did not Respond Fully to Amlodipine Monotherapy¥. Curr Vasc Pharmacol, 10(6), 773-80.
     
  266. Hagendorff A, Stöbe S, Tarr A, Pfeiffer D (2012). Die konventionelle Standarduntersuchung in der transthorakalen Echokardiographie bei Patienten mit degenerativer Aortenstenose. Ultraschall Med, 33(6), 520-43.
     
  267. Hagendorff A, Wüstenfeld J (2012). Herzultraschall - Möglichkeiten zur Diagnose einer nichtphysiologischen Wandverdickung. medical sports network, 1, 4-6.
     
  268. Hagendorff A (2012). Echokardiographische Notfalldiagnostik. Herz, 37(6), 675-86.
     
  269. Hagendorff A, Stoebe S, Tarr A, Pfeiffer D (2012). [Standard transthoracic echocardiography examination in patients with degenerative stenosis of the aortic valve] Ultraschall Med, 33(6), 520-543.
     
  270. Thiele H, Rach J, Klein N, Pfeiffer D, Hartmann A, Hambrecht R, Sick P, Eitel I, Desch S, Schuler G (2012). Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig Immediate versus early and late PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI Trial). Eur Heart J , 33(16), 2035-2043.
     
  271. Klein N, Klein M, Weglage H, Przibille O, Fischer S, Trappe HJ, Birkenhauer F, Pfeiffer D (2012). Clinical efficacy of left ventricular pacing vector programmability in cardiac resynchronization therapy defibrillator patients for management of phrenic nerve stimulation and/or elevated left ventricular pacing thresholds: Insights from the efface Phrenic Stim study. Europace, 14(6), 826-32.
     
  272. Carlsson J, Paul NW, Dann M, Neuzner J, Pfeiffer D (2012). The deactivation of implantable cardioverter-defibrillators: medical, ethical, practical, and legal considerations. Dtsch Ärztebl Int , 109(33-34), 535-541.
     
  273. Nickl W, Fürth R, Smettan J, Köhler T, Lankisch M, Kramer F, Barrose MC, Klein RM, Dinh W (2012). Assessment of aortic valve area combining echocardiography and magnetic resonance imaging. Arg Bras Cardiol, 98(3), 234-42.
     


  274. 2011


  275. Kluge JG, Jurisch D, Tarr A, Hagendorff A, Pfeiffer D (2011). Right atrial free floating thrombus in dilated cardiomyopathy. Eur J Echocardiograph, 12(10), 798.
     
  276. Kluge JG, Hagendorff A, Pfeiffer D, Jurisch D, Tarr A (2011). Active infective prosthetic endocarditis after percutaneous edge-to-edge mitral valve repair. Eur J Echocardiogr, 12(10), 710.
     
  277. Dhein S, Rothe S, Busch A, Rojas Gomez DM, Boldt A, Reutemann A, Seidel T, Salameh A, Pfannmüller B, Rastan A, Kostelka M, Mohr FW (2011). Effects of metoprolol therapy on cardiac gap junction remodelling and conduction in human chronic atrial fibrillation. Br J Pharmacol , 164(2b), 607-16.
     
  278. Thiele H, Eitel I, Meinberg C, Desch S, Leuschner A, Pfeiffer D, Hartmann A, Lotze U, Strauss W, Schuler G (2011). Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction). JACC Cardiovasc Intervent, 4(6, 605-614.
     
  279. Salameh A, Klein M, Klein N, Pfeiffer D, Dähnert I, Dhein S (2011). Coughing into the darkness. Lancet, 377(9778), 1718.
     
  280. Dinh W, Nickl W, Smettan J, Koehler T, Bansemir L, Lankisch M, Scheffold T, Barroso MC, Gülker JE, Füth R (2011). Relation of global longitudinal strain to left ventricular geometry in aortic stenosis. Cardiol J, 18(2), 151-6.
     
  281. Gehoff A, Kluge JG, Gehoff P, Jurisch D, Pfeiffer D, Hinz J, Popow AF (2011). Recurrent strokes under antiocoagulation therapy: Sticky platelet syndrom combined with patent foramen ovale. J Cardiovasc Dis Res, 2(1), 68-70.
     
  282. Hagendorff A (2011). Cardiac involvement in systemic diseases (chapter 18). In: Luigi Badano, The EAE Textbook of Echocardiography. (S. 1-18), Oxford: Oxford University Press.
     
  283. Neskovic AN, Hagendorff A (2011). Echocardiography in the Emergency room (chapter 24). In: Luigi Badano, The EAE Textbook of Echocardiography. (S. 1-13), Oxford: Oxford University Press.
     


  284. 2010


  285. Kluge JG, Körner I, Kluge G, Froster U, Pfeiffer D (2010). 35-year old patient with severe thromboembolism Internist, 51(12), 1567-1570.
     
  286. Kamper L, Smettan J, Abanador-Kamper N, Piroth W, Haltern G, Haage P (2010). Multimodal visualizaion of a retrocardial bronchial artery aneurysm with rare origin from the distal descending aorta. Clin Res Cardiol, 99(1), 51-52.
     
  287. Krizanic F, Sievert H, Pfeiffer D, Konorza T, Ferrari M, Hijazi Z, Jung C, Lauten A, Figulla HR (2010). The Occlutech Figulla PFO and ASD occluder: a new nitinol wire mesh device for closure of atrial septal defects. J Invasive Cardiol, 22(4), 182-7.
     
  288. Lancellotti P, Moura L, Pierard LA, Agricola E, Popescu BA, Tribouilloy C, Hagendorff A, Monin JL, Badano L, Zamorano JL (2010). European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr, 11(4), 307-32.
     
  289. Lancellotti P, Tribouilloy C, Hagendorff A, Moura L, Popescu BA, Agricola E, Monin JL, Pierard LA, Badano L, Zamorano JL (2010). European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). Eur J Echocardiogr, 11(3), 223-44.
     
  290. Schuler A, Reuss J, Delorme S, Hagendorff A, Giesel F (2010). Costs of clinical ultrasound examinations - an economical cost calculation and analysis. Ultraschall Med, 31(4), 379-86.
     
  291. Buck T, Breithardt OA, Faber L, Fehske W, Flachskampf FA, Franke A, Hagendorff A, Hoffmann R, Kruck I, Kücherer H, Menzel T, Pethig K, Tiemann K, Voigt JU, Weidemann F, Nixdorff U (2010). Erratum zu: Manual zur Indikation und Durchführung der Echokardiographie Clin Res Cardiol, 99(1), 63.
     
  292. Dinh W, Nickl W, Smettan J, Kramer F, Krahn T, Scheffold T, Barroso MC, Brinkmann H, Koehler T, Lankisch M, Füth R (2010). Reduced global longitudinal strain in association to increased left ventricular mass in patients with aortic valve stenosis and normal ejection fraction: a hybrid study combining echocardiography and magnetic resonance imaging Cardiovasc Ultrasound, 8, 29 ff.
     
  293. Flachskampf FA, Hagendorff A (2010). Koronare Herzkrankheit: Der Ischämienachweis ist der Angelpunkt der Diagnostik Deutsches Ärzteblatt, 107(34-35), 1627-32.
     


  294. 2009


  295. Jurisch D, Hagendorff A, Pfeiffer D (2009). [Do results of transoesophageal echocardiography during closure of patent foramen ovale influence interventional therapy?] Ultraschall Med, 30(1), 64-70.
     
  296. Pfeiffer D, Tebbenjohanns J (2009). [Herzchrittmachertherapie und Elektrophysiologie. Editorial] Herzschrittmacherther Elektrophysiol, 20(1), 3-4.
     
  297. Klein M, Klein N, Pfeiffer D (2009). Atriale Stimulation zur Prävention von Vorhofflimmern : Einfluss der septalen atrialen Stimulation mit atrialer Überstimulation und optimierter AV-Zeit auf die Vorhofflimmerlast Herzschrittmacherther Elektrophysiol, 20(3), 148-153.
     
  298. Pfeiffer D, Oeff, M (2009). Telemonitoring Herzschrittmacherther Elektrophysiol, 20(4), 163.
     
  299. Hemmer W, Rybak K, Markewitz A, Israel C, Kramer LI, Neuzner J, Nowak B, Pfeiffer D, Schuchert A, Wiegand U (2009). [Empfehlungen zur Strukturierung der Herzschrittmacher- und Defibrillatortherapie.] Thorac Cardiovasc Surg, 57(1), 1-10.
     
  300. Buck T, Breithardt OA, Faber T, Fehske W, Flachskampf FA, Franke A, Hagendorff A, Hoffmann R, Kruck I, Kücherer H, Menzel T, Pethig K, Thiemann K, Voigt JU, Weidemann F, Nixdorf U (2009). Manual zur Indikation und Durchführung der Echokardiographie. Clin Res Cardiol , Suppl. 4, 3-51.
     
  301. Salameh A, Krautblatter S, Karl S, Blanke K, Gomez DR, Dhein S, Pfeiffer D, Janousek J (2009). The signal transduction cascade regulating the expression of the gap junction protein connexin43 by beta-adrenoceptors. Br J Pharmacol, 158(1), 198-208.
     
  302. Schwab JO, Müller A, Oeff M, Neuzner J, Sack S, Pfeiffer D, Zugck C (2009). TeleMonitoring Systeme in der Kardiologie: Erfordernisse, Realisierungen, Zukunftsperspektiven. In: DGBMT, Tagungsband. (S. 1-47), Frankfurt: Verband der Elektrotechnik, Elektronik, Informatio.
     
  303. Hagendorff A (2009). kommentierte Video-loops auf der DVD. In: Neskovic AN, Flachskampf FA, Stress Echocardiography. Essential Guide and DVD. (S. 53-209), New York: Informa Healthcare.
     


  304. 2008


  305. Schneider HJ, Rossner S, Pfeiffer D, Hagendorff A (2008). d-ribose improves cardiac contractility and hemodynamics, and reduces expression of c-fos in the hippocampus during sustained slow ventricular tachycardia in rats. Int J Cardiol, 125(1), 49-56 .
     
  306. Kimmel S, Pfeiffer D, Schwarz J (2008). [Syncope. A diagnostic challenge.] Internist (Berl), 49(2), 185-198.
     
  307. Hagendorff A (2008). Transthoracic echocardiography in adult patients--a proposal for documenting a standardized investigation. Ultraschall Med, 29(4), 344-365.
     
  308. Hagendorff A, Kruck I, Merz E (2008). [Echocardiography: quo vadis?] Ultraschall Med, 29(2), 208-209.
     
  309. Salameh A, Krautblatter S, Baessler S, Karl S, Rojas Gomez D, Dhein S, Pfeiffer D (2008). Signal transduction and transcriptional control of cardiac connexin43 up-regulation after alpha 1-adrenoceptor stimulation. J Pharmacol Exp Ther, 326(1), 315-322.
     
  310. Schwab JO, Muller A, Oeff M, Neuzner J, Sack S, Pfeiffer D, Zugck C (2008). [Latest proceedings: remote medicine - ready for clinical practice?!] Herz, 33(6), 420-430.
     
  311. Oeff M, Muller A, Neuzner J, Sack S, Schwab JO, Pfeiffer D, Zugck C (2008). [ECG telemonitoring] Herzschrittmacherther Elektrophysiol, 19(3), 137-145.
     
  312. Muller A, Schwab JO, Oeff M, Neuzner J, Sack S, Pfeiffer D, Zugck C (2008). [Telemedicine--ready for use in the cardiological field?] Dtsch Med Wochenschr, 133(40), 2039-2044.
     
  313. Jurisch D, Szokodi D, Pfeiffer D, Kahn T, Engelmann L (2008). [A 49-year-old woman with deep vein thrombosis, pulmonary embolism, and left-sided paralysis] Internist (Berl), 49(10), 1251-1252.
     
  314. Krizanic F, Sievert H, Pfeiffer D, Konorza T, Ferrari M, Figulla HR (2008). Clinical evaluation of a novel occluder device (Occlutech) for percutaneous transcatheter closure of patent foramen ovale (PFO). Clin Res Cardiol, 97(12), 872-877.
     
  315. Watz H, Oltmanns A, Kimmel S, Magnussen H, Wirtz H, Kirsten D (2008). [Sporadic lymphangioleiomyomatosis. Clinical and lung functional characteristics of 32 female patients] Dtsch Med Wochenschr, 133(14), 705-708.
     


  316. 2007


  317. Schauer J (2007). Nachruf für Prof. Dr. med. Werner Ries Ärzteblatt Sachsen, 18(10), 534.
     
  318. Resetar ME, Ullmann C, Broeske P, Ludwig-Schindler K, Doll NK, Salameh A, Dhein S, Mohr FW (2007). Selective arterialization of a cardiac vein in a model of cardiac microangiopathy and macroangiopathy in sheep. J Thorac Cardiovasc Surg, 133(5), 1252-1256.
     
  319. Rabald S, Hagendorff A, Pfeiffer D, Zimmer HG, Deten A (2007). Contrast enhanced echocardiographic follow-up of cardiac remodeling and function after myocardial infarction in rats. Ultrasound Med Biol, 33(10), 1561-1571.
     
  320. Krug S, Seyfarth HJ, Hagendorff A, Wirtz H (2007). Inhaled iloprost for hepatopulmonary syndrome: improvement of hypoxemia. Eur J Gastroenterol Hepatol, 19(12), 1140-1143.
     
  321. Rassler B, Hallebach G, Kalischewski P, Baumann I, Schauer J, Spengler CM (2007). The effect of respiratory muscle endurance training in patients with myasthenia gravis. Neuromuscul Disord, 17(5), 385-391.
     


  322. 2006


  323. Salameh A, Frenzel C, Boldt A, Rassler B, Glawe I, Schulte J, Muhlberg K, Zimmer HG, Pfeiffer D, Dhein S (2006). Subchronic alpha- and beta-adrenergic regulation of cardiac gap junction protein expression. FASEB J, 20(2), 365-367.
     
  324. Klein N, Klein M, Salameh A, Pfeiffer D (2006). [Modern pacing therapy.] Internist (Berl), 47(10), 1024-1033.
     
  325. Teich N, Engelmann L, Pfeiffer D (2006). Laienreanimation: schlechte Kenntnisse in Deutschland. Der Notarzt, 22(4), 114-118.
     
  326. Kuhn H, Konrad J, Holtz S, Salameh A, Gessner C, Hammerschmidt S, Wirtz H (2006). Enhanced expression of VEGF following bFGF inhibition in non-small cell lung cancer cell lines. Lung Cancer, 54(2), 149-153.
     
  327. Kolb C, Wille B, Maurer D, Schuchert A, Weber R, Schibgilla V, Klein N, Hummer A, Schmitt C, Zrenner B (2006). Management of far-field R wave sensing for the avoidance of inappropriate mode switch in dual chamber pacemakers: results of the FFS-test study. J Cardiovasc Electrophysiol, 17(9), 992-997.
     
  328. Thiele H, Scholz M, Engelmann L, Storch WH, Hartmann A, Dimmel G, Pfeiffer D, Schuler G, Leipzig Prehospital Fibrinolysis Group (2006). ST-segment recovery and prognosis in patients with ST-elevation myocardial infarction reperfused by prehospital combination fibrinolysis, prehospital initiated facilitated percutaneous coronary intervention, or primary percutaneous coronary intervention. Am J Cardiol, 98(9), 1132-1139.
     
  329. Thiele H, Scholz M, Engelmann L, Storch WH, Hartmann A, Dimmel G, Pfeiffer D, Schuler G (2006). ST-segment recovery and prognosis in patients with ST-elevation myocardial infarction reperfused by prehospital combination fibrinolysis, prehospital initiated facilitated percutaneous coronary intervention, or primary percutaneous coronary intervention. Am J Cardiol, 98(9), 1132-1139.
     
  330. Kuhn H, Konrad J, Holtz S, Salameh A, Gessner C, Hammerschmidt S, Wirtz H (2006). Enhanced expression of VEGF following bFGF inhibition in non-small cell lung cancer cell lines. Lung Cancer, 54(2), 149-153.
     
  331. Mende L, Böhm R, Regenthal R, Klein N, Grond S, Radke J (2006). Hyperdynamischer Kreislaufstillstand nach Ingestion von Ecstasy. Notfall & Hausarztmedizin, 32(3), 154-157.
     
  332. Pfeiffer D, Salameh A, Hagendorff A (2006). Therapie des Vorhofflimmerns. In: Lewalter T, Rationale Arrhythmiebehandlung - Ein Paradigmenwechsel. (S. 115-123), Darmstadt: Steinkopf Verlag.
     
  333. Salameh A (2006). Life cycle of connexins: regulation of connexin synthesis and degradation. In: Dhein S, Cardiovascular gap junctions. (S. 57-70), Basel: Karger Verlag.
     
  334. Voigt H, Conradi E (2006). Die Bedeutung der Inneren Medizin, Geriatrie und Dermatologie. In: Conradi E, Voigt H, Innere Medizin, Geriatrie und Dermatologie für Physiotherapeuten. (S. 15-24), Zwickau: Verlag Wissenschaftliche Skripten.
     
  335. Voigt H, Conradi E, Mendel J (2006). Herz-Kreislauferkrankungen. In: Conradi E, Voigt H, Innere Medizin, Geriatrie und Dermatologie für Physiotherapeuten. (S. 29-103), Zwickau: Verlag Wissenschaftliche Skripten.
     
  336. Voigt H, Mendel J, Conradi E (2006). Krankheiten der Atmungsorgane. In: Conradi E, Voigt H, Innere Medizin, Geriatrie und Dermatologie für Physiotherapeuten. (S. 105-157), Zwickau: Verlag Wissenschaftlicher Skripten.
     
  337. Voigt H, Conradi E (2006). Krankheiten des Verdauungssystems. In: Conradi E, Voigt H, Innere Medizin, Geriatrie und Dermatologie für Physiotherapeuten. (S. 215-278), Zwickau: Verlag Wissenschaftlicher Skripten.
     
  338. Voigt H, Conradi E (2006). Störungen des Stoffwechsels und der inneren Sekretion. In: Conradi E, Voigt H, Innere Medizin, Geriatrie und Dermatologie für Physiotherapeuten. (S. 279-317), Zwickau: Verlag Wissenschaftlicher Skripten.
     
  339. Conradi E, Voigt H (2006). Erkrankungen der Niere und Harnwege. In: Conradi E, Voigt H, Innere Medizin, Geriatrie und Dermatologie für Physiotherapeuten. (S. 319-340), Zwickau: Verlag Wissenschaftlicher Skripten.
     
  340. Voigt H, Mendel J (2006). Blutkrankheiten und Blutgerinnungsstörungen. In: Conradi E, Voigt H, Innere Medizin, Geriatrie und Dermatologie für Physiotherapeuten. (S. 341-352), Zwickau: Verlag Wissenschaftliche Skripten.
     
  341. Voigt H, Conradi E, Mendel J (2006). Besonderheiten des alternden Menschen-Bedeutung der Geriatrie. In: Conradi E, Voigt H, Innere Medizin, Geriatrie und Dermatologie für Physiotherapeuten. (S. 353-374), Zwickau: Verlag Wissenschaftliche Skripten.
     
  342. Conradi E, Voigt H (2006). Infektionskrankheiten-Einführung. In: Conradi E, Voigt H, Innere Medizin, Geriatrie und Dermatologie für Physiotherapeuten. (S. 375-391), Zwickau: Verlag Wissenschaftliche Skripten.
     


  343. 2005


  344. Scheid R, Voigt H (2005). [Arterial hypertension and dementia] Nervenarzt, 76(2), 143-153.
     
  345. Hagendorff A, Pfeiffer D (2005). [Echocardiographic functional analysis of patients with rheumatoid arthritis and collagen diseases] Z Rheumatol, 64(4), 239-248.
     
  346. Teich N, Engelmann L, Pfeiffer D (2005). [Resuscitation by laypersons: lack of knowledge of first-aid measures in Germany] Dtsch Med Wochenschr, 130(48), 2759-2762.
     
  347. Salameh A, Mühlberg K, Schneider P, Dhein S, Pfeiffer D (2005). Differential regulation of gap junction proteins connexin 40 and connexin 43 in cardiomyocytes Int J Pharmacol, 1(1), 44-54.
     
  348. Salameh A, Dhein S (2005). Pharmacology of Gap junctions. New pharmacological targets for treatment of arrhythmia, seizure and cancer? Biochim Biophys Acta, 1719(1-2), 36-58.
     
  349. Gessner C, Guttler A, Hammerschmidt S, Pfeiffer D, Wirtz H (2005). [Rare cause of pectangina after coronary artery surgery] Internist (Berl), 46(8), 913-916.
     
  350. Wirtz HR (2005). [Chronic bronchitis, COPD] Internist (Berl), 46(2), 175-92.
     
  351. Lemke B, Nowak B, Pfeiffer D (2005). Leitlinien zur Herzschrittmachertherapie. Z Kardiol, 94(10), 704-720.
     
  352. Wiedmann M, Hagendorff A, Bohm R, Schulz T, Mossner J, Caca K (2005). Malignant oesophago-pleuro-pericardial fistula in a patient with oesophageal carcinoma. Z Kardiol, 94(6), 411-414.
     
  353. Fehske W, Buck T, Hagendorff A, von Bardeleben RS, Voelker W, Heinemann S (2005). [Quality assurance in echocardiography. Three-level system in formation and qualifying and concept of an external quality review] Z Kardiol, 94(1), 61-73.
     
  354. Thiele H, Engelmann L, Elsner K, Kappl MJ, Storch WH, Rahimi K, Hartmann A, Pfeiffer D, Kneissl GD, Schneider D, Moller T, Heberling HJ, Weise I, Schuler G (2005). Comparison of pre-hospital combination-fibrinolysis plus conventional care with pre-hospital combination-fibrinolysis plus facilitated percutaneous coronary intervention in acute myocardial infarction. Eur Heart J, 26(19), 1956-1963.
     
  355. Mende L, Bohm R, Regenthal R, Klein N, Grond S, Radke J (2005). [Cardiac arrest caused by an ecstasy intoxication.] Anasthesiol Intensivmed Notfallmed Schmerzther, 40(12), 762-765.
     
  356. Horvath I, Hunt J, Barnes PJ, Alving K, Antczak A, Baraldi E, Becher G, van Beurden WJ, Corradi M, Dekhuijzen R, Dweik RA, Dwyer T, Effros R, Erzurum S, Gaston B, Gessner C, Greening A, Ho LP, Hohlfel (2005). Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J, 26(3), 523-548.
     
  357. Emmrich P, Ogunlade V, Gradistanac T, Daneschnejad S, Koch MC, Schober R (2005). [Facioscapulohumeral muscle dystrophy and heart disease] Z Kardiol, 94(5), 348-354.